News | September 24, 2012

Top 10 Changes to U.S. FDA Medical Device Registrations and Listings

Registrar Corp reports on the top 10 changes the new U.S. Food and Drug Administration Safety and Innovation Act (FDASIA) imposes on Medical Device Registrations and Listings.

September 24, 2012—The new U.S. Food and Drug Administration Safety and Innovation Act (FDASIA) imposes many Medical Device Establishment Registration and Listings requirements, effective Oct. 1, 2012. To assist the medical device industry, Registrar Corp has provided the following list of top 10 things that medical device professionals need to know regarding FDASIA:

  1. All proprietary names under which a medical device is marketed must be reported, at a minimum, when a medical device is first listed and during the annual update of registration and listing information.
  2. Combination products (i.e. products comprising a medical device and a biological product or a drug) must be identified as a combination product and the type of combination product.
  3. All contract manufacturers and sterilizers of finished medical devices must register and list regardless of whether they put the medical device into commercial distribution or return the medical device to the manufacturer or specification developer.
  4. Initial importers must identify the manufacturers of the medical devices they are importing.
  5. Foreign establishments that are exporting medical devices or offering medical devices for export to the United States must identify all known U.S. importers of their devices.
  6. A device must be listed by the manufacturer, specification developer, single-use medical device reprocessor, remanufacturer or repacker /relabeler before a foreign exporter, contract manufacturer or contract sterilizer can list it.
  7. Establishments that only handle complaints and previously registered as manufacturers or specification developers should change their establishment type to “Complaint File Establishment.”
  8. Establishments located in foreign trade zones must now register and list, as well as identify themselves as being located in a foreign trade zone.
  9. All establishments that are required to register must now pay the annual registration user fee as required by FDASIA.
  10. To have your medical device registration, renewal and listing submitted to FDA by a Regulatory Specialist, simply contact Registrar Corp at +1-757-224-0177. Registrar Corp’s regulatory specialists are available to assist you as the new requirements take effect on Oct. 1, 2012.

 

For more information: www.registrarcorp.com/livehelp

Related Content

Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Feature | Computed Tomography (CT) | May 30, 2019 | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging mod
Vast Majority of Heavy Smokers Not Screened for Lung Cancer
News | Lung Cancer | May 29, 2019
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...